HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atanaska Elenkova Selected Research

Transforming Growth Factors (Transforming Growth Factor)

9/2013Transforming growth factor β1 is not a reliable biomarker for valvular fibrosis but could be a potential serum marker for invasiveness of prolactinomas (pilot study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atanaska Elenkova Research Topics

Disease

5Neoplasms (Cancer)
02/2024 - 01/2013
5Prolactinoma (Prolactinomas)
06/2023 - 07/2012
5Acromegaly
01/2023 - 08/2015
4Cushing Syndrome
12/2022 - 11/2019
3Hypertension (High Blood Pressure)
11/2022 - 06/2010
2Prediabetic State (Prediabetes)
03/2021 - 02/2020
2Pituitary Neoplasms (Pituitary Adenoma)
03/2021 - 10/2011
2Diabetes Mellitus
02/2020 - 06/2010
2Pheochromocytoma
02/2020 - 06/2010
2Fibrosis (Cirrhosis)
09/2013 - 07/2012
1Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2024
1Hyperthyroidism
06/2023
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2021
1Type 2 Diabetes Mellitus (MODY)
03/2021
1Morbid Obesity
03/2021
1Pituitary ACTH Hypersecretion
03/2021
1Paraganglioma (Paragangliomas)
02/2020
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
01/2019
1Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
01/2019
1Disease Progression
02/2016
1Carcinogenesis
09/2013
1Heart Valve Diseases (Valvular Heart Disease)
09/2013
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2013
1Hyperprolactinemia
01/2013
1Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2012
1Insulin Resistance
06/2010
1Essential Hypertension
06/2010

Drug/Important Bio-Agent (IBA)

4Dopamine Agonists (Dopamine Agonist)IBA
01/2023 - 07/2012
4Hydrocortisone (Cortisol)FDA LinkGeneric
12/2022 - 11/2019
3ProlactinIBA
01/2023 - 09/2013
3Glucose (Dextrose)FDA LinkGeneric
02/2020 - 06/2010
2CabergolineFDA LinkGeneric
01/2023 - 07/2012
2aryl hydrocarbon receptor-interacting proteinIBA
01/2023 - 10/2011
2Hormones (Hormone)IBA
11/2022 - 03/2021
2CatecholaminesIBA
03/2021 - 06/2010
2NormetanephrineIBA
03/2021 - 02/2020
2MetanephrineIBA
03/2021 - 02/2020
2CarbohydratesIBA
03/2021 - 02/2020
2Insulin (Novolin)FDA Link
02/2020 - 06/2010
1RNA (Ribonucleic Acid)IBA
02/2024
1MicroRNAs (MicroRNA)IBA
02/2024
1Thyroxine (Levothyroxine)FDA LinkGeneric
06/2023
1AntibodiesIBA
06/2023
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
06/2023
1Octreotide (Sandostatin)FDA LinkGeneric
12/2022
1SteroidsIBA
11/2022
1Cytidine Triphosphate (CTP)IBA
03/2021
1Epinephrine (Adrenaline)FDA LinkGeneric
02/2020
1Dipeptidyl-Peptidase IV InhibitorsIBA
02/2020
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
02/2020
1SodiumIBA
02/2020
1Ketoconazole (Nizoral)FDA LinkGeneric
11/2019
1EnzymesIBA
01/2019
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
08/2015
1Insulin-Like Growth Factor I (IGF-1)IBA
08/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2013
1Biomarkers (Surrogate Marker)IBA
09/2013
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
09/2013
1alpha-2-HS-GlycoproteinIBA
09/2013
1polymeric prolactin (BPRL)IBA
01/2013
1Protein Isoforms (Isoforms)IBA
01/2013
1amsonic acid (DAS)IBA
07/2012
1Bromocriptine (Parlodel)FDA LinkGeneric
07/2012
1AdiponectinIBA
06/2010

Therapy/Procedure

4Therapeutics
01/2023 - 01/2013
1Adrenalectomy
03/2021
1Radiotherapy
03/2021
1Drug Therapy (Chemotherapy)
01/2020